Kaposi's sarcoma of the head and neck: a review.

[1]  Blossom Damania,et al.  Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. , 2010, Cancer letters.

[2]  B. Gazzard,et al.  The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma , 2009, AIDS.

[3]  H. Coovadia,et al.  Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983–2006) , 2009, International journal of STD & AIDS.

[4]  J. Goedert,et al.  Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. , 2009, Annals of epidemiology.

[5]  G. Goldenberg,et al.  Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40. , 2009, Journal of the American Academy of Dermatology.

[6]  S. Rayner,et al.  Seroprevalence of Kaposi's sarcoma‐associated herpesvirus and risk factors in Xinjiang, China , 2009, Journal of medical virology.

[7]  Jeffrey N. Martin,et al.  Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. , 2009, The Journal of infectious diseases.

[8]  P. Ahmadpoor.  Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis. , 2009, Iranian journal of kidney diseases.

[9]  A. Tappuni,et al.  Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[10]  E. Selva,et al.  LANA-1, Bcl-2, Mcl-1 and HIF-1α protein expression in HIV-associated Kaposi sarcoma , 2009, Virchows Archiv.

[11]  C. Pannuti,et al.  High Human Herpesvirus 8 (HHV-8) Prevalence, Clinical Correlates and High Incidence among Recently HIV-1-Infected Subjects in Sao Paulo, Brazil , 2009, PloS one.

[12]  S. Franceschi,et al.  Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. , 2009, The Journal of infectious diseases.

[13]  E. Arbustini,et al.  Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. , 2009, Transplantation proceedings.

[14]  G. Reyes-Terán,et al.  Identification of oral candidosis, hairy leukoplakia and recurrent oral ulcers as distinct cases of immune reconstitution inflammatory syndrome , 2009, International journal of STD & AIDS.

[15]  L. Pignataro,et al.  An Unusual Cause of a Parotid Mass in an Immunocompetent Host: Classic Kaposi's Sarcoma , 2009, Tumori.

[16]  S. Porter,et al.  Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient. , 2009, Oral microbiology and immunology.

[17]  A. Patrikidou,et al.  Non‐AIDS Kaposi's sarcoma in the head and neck area , 2009, Head & neck.

[18]  J. Weissfeld,et al.  Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior , 2009, Journal of medical virology.

[19]  V. Ramírez-Amador,et al.  Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  A. Wald,et al.  Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda , 2009, PloS one.

[21]  R. Arav-Boger.  Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments , 2009, Virus Genes.

[22]  D. Whitby,et al.  Kaposi's sarcoma-associated herpesvirus transmission and primary infection , 2009, Current opinion in HIV and AIDS.

[23]  W. Whittington,et al.  Prevalence and Correlates of Human Herpesvirus 8 Infection Among Peruvian Men Who Have Sex With Men , 2008, Journal of acquired immune deficiency syndromes.

[24]  C. Tinelli,et al.  HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma , 2008, Journal of medical virology.

[25]  J. Goedert,et al.  Risk Factors for Classical Kaposi Sarcoma in a Population-based Case-control Study in Sicily , 2008, Cancer Epidemiology Biomarkers & Prevention.

[26]  G. Lorenzo.  Update on classic Kaposi sarcoma therapy: New look at an old disease , 2008 .

[27]  E. Cesarman,et al.  The pathobiology of Kaposi’s sarcoma: advances since the onset of the AIDS epidemic , 2008, Journal of cutaneous pathology.

[28]  K. Shokat,et al.  Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. , 2008, Cancer research.

[29]  C. Lebbé,et al.  Kaposi sarcoma in transplantation. , 2008, Transplantation reviews.

[30]  Corey Casper.  New approaches to the treatment of human herpesvirus 8‐associated disease , 2008, Reviews in medical virology.

[31]  R. A. Schwartz,et al.  Kaposi sarcoma: a continuing conundrum. , 2008, Journal of the American Academy of Dermatology.

[32]  C. Kankasa,et al.  Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. , 2008, American journal of epidemiology.

[33]  D. Podzamczer,et al.  Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  L. Pantanowitz,et al.  Kaposi sarcoma in unusual locations , 2008, BMC Cancer.

[35]  J. Goedert,et al.  Cancer risk in people infected with human immunodeficiency virus in the United States , 2008, International journal of cancer.

[36]  A. Wald,et al.  Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. , 2008, The Journal of infectious diseases.

[37]  Lara Stein,et al.  Part I: Cancer in Indigenous Africans--burden, distribution, and trends. , 2008, The Lancet. Oncology.

[38]  C. Lebbé,et al.  Kaposi's sarcoma in HIV-negative men having sex with men , 2008, AIDS.

[39]  R. Piccinno,et al.  Radiotherapy of classic and human immunodeficiency virus‐related Kaposi's sarcoma: results in 1482 lesions , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[40]  E. Babin,et al.  Unusual presentation of oropharyngeal Kaposi's sarcoma , 2008, Head & neck.

[41]  F. Sitas,et al.  No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population , 2008, AIDS.

[42]  N. Wood,et al.  Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. , 2008, Journal of periodontology.

[43]  P. Åman,et al.  Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib , 2008, Cancer Cell International.

[44]  C. Castilletti,et al.  Incidence of Human Herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections , 2007, BMC infectious diseases.

[45]  A. Khabir,et al.  Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment. , 2007, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[46]  N. Wood,et al.  HIV-associated Kaposi sarcoma: pathogenic mechanisms. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[47]  J. Jabłecki,et al.  Kaposi's sarcoma revisited. , 2007, AIDS reviews.

[48]  C. Pannuti,et al.  Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. , 2007, The Journal of infectious diseases.

[49]  E. Gotuzzo,et al.  Classic Kaposi's sarcoma presenting in the oral cavity of two HIV-negative Quechua patients. , 2007, Medicina oral, patologia oral y cirugia bucal.

[50]  P. Pellett,et al.  Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma , 2007, AIDS.

[51]  C. Lebbé,et al.  Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. , 2007, Journal of the National Cancer Institute.

[52]  C. Brander,et al.  Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma , 2007, AIDS.

[53]  P. Biberfeld,et al.  Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association. , 2007, Oncology reports.

[54]  L. Pantanowitz,et al.  Acquired immunodeficiency syndrome related Kaposi's sarcoma eroding the maxillary bone , 2007, The Journal of Laryngology & Otology.

[55]  G. Liomba,et al.  Spectrum and presentation of pediatric malignancies in the HIV era: Experience from Blantyre, Malawi, 1998–2003 , 2007, Pediatric blood & cancer.

[56]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. , 2007, Cancer research.

[57]  F. Pica,et al.  Transmission of human herpesvirus 8: an update , 2007, Current opinion in infectious diseases.

[58]  R. Correa-Rotter,et al.  Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not" , 2007, BMC nephrology.

[59]  L. Pantanowitz,et al.  Kaposi sarcoma of the musculoskeletal system , 2007, Cancer.

[60]  R. Pfeiffer,et al.  Transmission of Kaposi Sarcoma-Associated Herpesvirus Between Mothers and Children in a South African Population , 2007, Journal of acquired immune deficiency syndromes.

[61]  S. Montaner.  Akt/TSC/mTOR Activation by the KSHV G Protein-Coupled Receptor: Emerging Insights into the Molecular Oncogenesis and Treatment of Kaposi’s Sarcoma , 2007, Cell cycle.

[62]  L. Pantanowitz,et al.  Management of AIDS-related Kaposi's sarcoma. , 2007, The Lancet. Oncology.

[63]  N. Inoue,et al.  Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma , 2007, Journal of medical virology.

[64]  T. Schulz,et al.  Risk factors for human Herpesvirus 8 infection and AIDS‐associated Kaposi's sarcoma among men who have sex with men in a European multicentre study , 2006, International journal of cancer.

[65]  E. Engels,et al.  Kaposi's sarcoma risk among transplant recipients in the United States (1993–2003) , 2006, International journal of cancer.

[66]  R. Sullivan,et al.  Emerging targets and novel strategies in the treatment of AIDS‐related Kaposi's sarcoma: Bidirectional translational science , 2006, Journal of cellular physiology.

[67]  T. Simonart.  Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. , 2006, Cancer letters.

[68]  L. Naldi,et al.  Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. , 2006, European journal of dermatology : EJD.

[69]  P. Schmid‐Grendelmeier,et al.  HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence. , 2006, European journal of dermatology : EJD.

[70]  J. Goedert,et al.  Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma , 2006, Cancer.

[71]  P. Biberfeld,et al.  Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development , 2006, International journal of cancer.

[72]  R. Weber,et al.  Human Herpesvirus 8 Oral Shedding in HIV-Infected Men With and Without Kaposi Sarcoma , 2006, Journal of acquired immune deficiency syndromes.

[73]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[74]  A. Wald,et al.  HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study , 2006, Sexually Transmitted Infections.

[75]  C. Bacchi,et al.  Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[76]  J. Webster-Cyriaque,et al.  Oral EBV and KSHV Infection in HIV , 2006, Advances in dental research.

[77]  C. Katlama,et al.  Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy , 2006, British Journal of Cancer.

[78]  D. Ganem,et al.  KSHV infection and the pathogenesis of Kaposi's sarcoma. , 2006, Annual review of pathology.

[79]  E. Arbustini,et al.  Kaposi’s Sarcoma in Transplant and HIV-infected Patients: An Epidemiologic Study in Italy and France , 2005, Transplantation.

[80]  S. Linn,et al.  Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma. , 2005, Archives of dermatology.

[81]  M. Glick,et al.  Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[82]  D. Aboulafia,et al.  Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. , 2005, AIDS patient care and STDs.

[83]  P. Mayaud,et al.  AIDS‐related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub‐Saharan Africa , 2005, Tropical medicine & international health : TM & IH.

[84]  E. Gotuzzo,et al.  Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. , 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[85]  A. Gessain,et al.  Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus‐8 LNA‐1 , 2005, Pathology.

[86]  C. Thirlwell,et al.  Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  L. Pantanowitz,et al.  AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. , 2005, The oncologist.

[88]  R. Sessions,et al.  Kaposi's Sarcoma of an Intraparotid Lymph Node Leading to a Diagnosis of HIV , 2005, The Laryngoscope.

[89]  J. Kaldor,et al.  Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia. , 2005, Sexual health.

[90]  G. Banna,et al.  Treatments of AIDS-related Kaposi's sarcoma. , 2005, Critical reviews in oncology/hematology.

[91]  Harvey Schipper,et al.  Treatment of AIDS‐associated Kaposi's sarcoma in Zimbabwe: Results of a randomized quality of life focused clinical trial , 2005, International journal of cancer.

[92]  S. Remick,et al.  Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya , 2005, Annals of tropical medicine and parasitology.

[93]  P. Swanson,et al.  Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation , 2005, International journal of STD & AIDS.

[94]  P. Biberfeld,et al.  HHV‐8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry , 2005, Journal of cutaneous pathology.

[95]  S. Franceschi,et al.  Classic Kaposi's sarcoma in Italy, 1985–1998 , 2004, British Journal of Cancer.

[96]  Elizabeth Brazeau,et al.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. , 2004, Virology.

[97]  J. Goedert,et al.  Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. , 2004, The Journal of infectious diseases.

[98]  J. Goedert,et al.  The Incidence of Kaposi Sarcoma Among Injection Drug Users With AIDS in the United States , 2004, Journal of acquired immune deficiency syndromes.

[99]  T. Schulz,et al.  Mother-to-child transmission of human herpesvirus-8 in South Africa. , 2004, The Journal of infectious diseases.

[100]  R. Schwartz.  Kaposi's sarcoma: An update , 2004, Journal of surgical oncology.

[101]  R. Greenblatt,et al.  Prevalence of Human Herpesvirus-8 Salivary Shedding in HIV Increases with CD4 Count , 2004, Journal of dental research.

[102]  B. Chohan,et al.  Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. , 2004, The Journal of infectious diseases.

[103]  A. Mocroft,et al.  The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003 , 2004, Cancer.

[104]  M. Gazouli,et al.  Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. , 2004, Artificial organs.

[105]  E. Castaños-Vélez,et al.  Human Herpesvirus 8/Kaposi Sarcoma Herpesvirus Cell Association During Evolution of Kaposi Sarcoma , 2004, Journal of acquired immune deficiency syndromes.

[106]  Z. Kyriakopoulou,et al.  Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients. , 2004, Oral microbiology and immunology.

[107]  C. Grose,et al.  Wild-Type Kaposi's Sarcoma-Associated Herpesvirus Isolated from the Oropharynx of Immune-Competent Individuals Has Tropism for Cultured Oral Epithelial Cells , 2004, Journal of Virology.

[108]  U. Tirelli,et al.  Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  R. Dorfman,et al.  Human Herpesvirus-8 Latent Nuclear Antigen-1 Expression in Endemic Kaposi Sarcoma: An Immunohistochemical Study of 16 Cases , 2003, The American journal of surgical pathology.

[110]  H. Coleman,et al.  Oral Kaposi's sarcoma: a clinicopathologic study from South Africa. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[111]  M. Ghoneim,et al.  Clinical Features and Course of Kaposi's Sarcoma in Egyptian Kidney Transplant Recipients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[112]  C. Cobb,et al.  Oral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature. , 2003, Journal of periodontology.

[113]  C. Scully,et al.  Multiple human herpesvirus-8 infection. , 2003, The Journal of infectious diseases.

[114]  G. Rezza,et al.  Human herpesvirus 8 epidemiology: what we do and do not know. , 2003 .

[115]  B. Gazzard,et al.  A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma , 2003, AIDS.

[116]  P. Pellett,et al.  Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. , 2003, Journal of acquired immune deficiency syndromes.

[117]  S. Verma,et al.  Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. , 2003, FEMS microbiology letters.

[118]  Y. Gwack,et al.  Global Changes in Kaposi's Sarcoma-Associated Virus Gene Expression Patterns following Expression of a Tetracycline-Inducible Rta Transactivator , 2003, Journal of Virology.

[119]  F. Buonaguro,et al.  Kaposi's sarcoma: aetiopathogenesis, histology and clinical features , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[120]  S. Ferrucci,et al.  Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. , 2003, European journal of dermatology : EJD.

[121]  R. Newton,et al.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma , 2003, British Journal of Cancer.

[122]  J. Goedert,et al.  Risk factors for classical Kaposi's sarcoma. , 2002, Journal of the National Cancer Institute.

[123]  J. Baeten,et al.  Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya , 2002, AIDS.

[124]  A. Jemal,et al.  Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. , 2002, Journal of the National Cancer Institute.

[125]  B. Druker,et al.  Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kit Proto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells , 2002, Journal of Virology.

[126]  J. Reis-Filho,et al.  Classic Kaposi's sarcoma of the tongue: case report with emphasis on the differential diagnosis. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[127]  C. Teo,et al.  Mixed patterns of transmission of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) in Malawian families. , 2002, The Journal of general virology.

[128]  A. Mohar,et al.  Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial. , 2002, Oral oncology.

[129]  C. Ferreli,et al.  Parotid mass as an early sign of Kaposi’s sarcoma associated with human herpesvirus 8 infection , 2002, The Journal of Laryngology & Otology.

[130]  Thomas Ruzicka,et al.  Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. , 2002, The Lancet. Infectious diseases.

[131]  E. Ok,et al.  Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[132]  B. Dezube.  Management of AIDS-related Kaposi’s sarcoma: advances in target discovery and treatment , 2002, Expert review of anticancer therapy.

[133]  A. Wald,et al.  Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. , 2002, The Journal of infectious diseases.

[134]  Alexander Marks,et al.  Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.

[135]  E. Nicastri,et al.  Primary human herpesvirus 8 infection in immunocompetent children. , 2002, JAMA.

[136]  A. Karam,et al.  Photodynamic therapy of sebaceous hyperplasia with topical 5‐aminolaevulinic acid and slide projector , 2002, The British journal of dermatology.

[137]  M. Kudo,et al.  Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China , 2001, Pathology international.

[138]  E. Nicastri,et al.  Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. , 2001, AIDS.

[139]  P. Monini,et al.  Biology of Kaposi's sarcoma. , 2001, European journal of cancer.

[140]  D. Vlahov,et al.  Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. , 2001, The New England journal of medicine.

[141]  J. Goedert,et al.  Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. , 2001, International journal of cancer.

[142]  A. Wald,et al.  Mucosal shedding of human herpesvirus 8 in men. , 2000, The New England journal of medicine.

[143]  S. Steinberg,et al.  An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. , 2000, Blood.

[144]  D. Trégouët,et al.  Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population , 2000, The Lancet.

[145]  H. Jaffe,et al.  Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. , 2000 .

[146]  C. Buchrieser,et al.  Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. , 2000, Journal of the National Cancer Institute.

[147]  Y. Chang,et al.  Kaposi's sarcoma. , 2000, The New England journal of medicine.

[148]  D. Parkin,et al.  Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997 , 2000, British Journal of Cancer.

[149]  C. Payá,et al.  Kaposi's Sarcoma and Transplantation. , 2000, Herpes : the journal of the IHMF.

[150]  R. Geskus,et al.  Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. , 2000, American journal of epidemiology.

[151]  J. Goedert,et al.  Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. , 2000, International journal of epidemiology.

[152]  S. Franceschi,et al.  Classic Kaposi sarcoma , 2000, Cancer.

[153]  F. Tekaia,et al.  Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America , 2000, International journal of cancer.

[154]  D. Parkin,et al.  Aids and cancer in Africa: the evolving epidemic in Zimbabwe. , 1999, AIDS.

[155]  C. Boshoff,et al.  Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa , 1999, British Journal of Cancer.

[156]  P. Monini,et al.  Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. , 1999, Journal of the National Cancer Institute.

[157]  C. Boshoff,et al.  Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. , 1999, The Journal of infectious diseases.

[158]  A. Nel,et al.  Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. , 1999, Journal of immunology.

[159]  V. Beral,et al.  Antibodies against human herpesvirus 8 in black South African patients with cancer. , 1999, The New England journal of medicine.

[160]  E. Jaffe,et al.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.

[161]  G. de Thé,et al.  Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa , 1999, International journal of cancer.

[162]  B. Chandran,et al.  Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. , 1999, Virology.

[163]  C. Kankasa,et al.  Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. , 1998, The Journal of infectious diseases.

[164]  V. Beral,et al.  The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. , 1998, British Journal of Cancer.

[165]  R. Schooley,et al.  Comparison of the prevalence of antibodies to human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Brazil and Colorado. , 1998, The Journal of infectious diseases.

[166]  P. Brennan,et al.  Classic Kaposi's sarcoma in Jews living in Israel, 1961–1989: a population‐based incidence study , 1998, AIDS.

[167]  R. Biggar,et al.  Increasing Kaposi's sarcoma‐associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 , 1998, AIDS.

[168]  L. Cuevas,et al.  Prevalence and transmission of Kaposi's sarcoma‐associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents , 1998, International journal of cancer.

[169]  J. Morvan,et al.  High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8 , 1998, Transfusion.

[170]  P. Brennan,et al.  Classic Kaposi's sarcoma in Arabs living in Israel, 1970–1993: A population‐based incidence study , 1998, International journal of cancer.

[171]  F. Caprilli,et al.  Prevalence and determinants of anti‐lytic and anti‐latent antibodies to human herpesvirus‐8 among Italian individuals at risk of sexually and parenterally transmitted infections , 1998, International journal of cancer.

[172]  B. Nathwani,et al.  Evidence for multiclonality in multicentric Kaposi's sarcoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[173]  M. Kaplan,et al.  Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. , 1998, Blood.

[174]  R. Sun,et al.  High Prevalence of Antibodies to Human Herpesvirus 8 in Relatives of Patients with Classic Kaposi's Sarcoma from Sardinia , 1998 .

[175]  Jeffrey N. Martin,et al.  Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.

[176]  M. Crespo-Leiro,et al.  Detection of herpesvirus-like sequences in Kaposi's sarcoma from heart transplant recipients. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[177]  M. Feinmesser,et al.  Detection of human herpesvirus-8 DNA in Kaposi's sarcomas from iatrogenically immunosuppressed patients. , 1998, Journal of the American Academy of Dermatology.

[178]  R. Sun,et al.  Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. , 1998, Transplantation.

[179]  M. Moroni,et al.  Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. , 1997, Blood.

[180]  L. Corey,et al.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma , 1997, Journal of virology.

[181]  É. Oksenhendler,et al.  Molecular analysis of clonality in Kaposi's sarcoma. , 1997, Journal of clinical pathology.

[182]  B. Chandran,et al.  Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. , 1997, The Journal of infectious diseases.

[183]  D. Cooper,et al.  Risk of Kaposi's sarcoma and oroanal sexual contact. , 1997, American journal of epidemiology.

[184]  L. Liotta,et al.  Monoclonal origin of multicentric Kaposi's sarcoma lesions. , 1997, The New England journal of medicine.

[185]  F. Kasolo,et al.  Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. , 1997, The Journal of general virology.

[186]  R. Sun,et al.  Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen , 1997, Journal of virology.

[187]  D. Howells,et al.  HHV8 and Kaposi's sarcoma: a time cohort study. , 1997, Molecular pathology : MP.

[188]  I. Syndikus,et al.  High dose rate Microselectron moulds for Kaposi sarcoma of the palate. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[189]  D. Karcher,et al.  Human herpesvirus‐8/Kaposi's sarcoma‐associated herpesvirus in organ transplant patients with immunosupression , 1997, British journal of haematology.

[190]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[191]  J. Levy,et al.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients , 1996, The Lancet.

[192]  B. Gazzard,et al.  Anti‐herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection , 1996, AIDS.

[193]  F. Gudat,et al.  Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. , 1996, Journal of clinical pathology.

[194]  J. Meynard,et al.  Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. , 1996, The Journal of infectious diseases.

[195]  J. Phair,et al.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.

[196]  J. J. Li,et al.  Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcoma. , 1996, The Journal of clinical investigation.

[197]  N. Bendsøe,et al.  Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. , 1996, The American journal of pathology.

[198]  J. Phair,et al.  Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. , 1996, The Journal of infectious diseases.

[199]  Y. Jin,et al.  Presence of human herpesvirus-like DNA sequence in oral Kaposi's sarcoma. A preliminary PCR study. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[200]  J. Ziegler,et al.  Kaposi's sarcoma in childhood: An analysis of 100 cases from Uganda and relationship to HIV infection , 1996, International journal of cancer.

[201]  A. Hatzakis,et al.  Herpesvirus‐like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies , 1996, International journal of cancer.

[202]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[203]  C. Chintu,et al.  Childhood cancers in Zambia before and after the HIV epidemic. , 1995, Archives of disease in childhood.

[204]  M. Kaplan,et al.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma , 1995, The Lancet.

[205]  R. Biggar,et al.  AIDS-related Kaposi's sarcoma is a clonal neoplasm. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[206]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[207]  D. Parkin,et al.  Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[208]  J. Regezi,et al.  Oral Kaposi's sarcoma: a 10-year retrospective histopathologic study. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[209]  D. Parkin,et al.  Cancer in Kampala, Uganda, in 1989–91: Changes in incidence in the era of aids , 1993, International journal of cancer.

[210]  A. Mohar,et al.  Oral findings in Mexican AIDS patients with cancer. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[211]  V. Beral,et al.  Kaposi's sarcoma in England and Wales before the AIDS epidemic. , 1992, British Journal of Cancer.

[212]  C. Vogel,et al.  Kaposi's sarcoma in Uganda: A clinico‐pathological study , 1971, International journal of cancer.

[213]  L. Pantanowitz,et al.  Targeted Therapy for Kaposi Sarcoma , 2012, BioDrugs.

[214]  A. Wald,et al.  Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. , 2007, The Journal of infectious diseases.

[215]  A. Stewart,et al.  Infectious Agents and Cancer BioMed Central Review The Rho-activating CNF1 toxin from pathogenic E. coli: A risk , 2007 .

[216]  S. Pittaluga,et al.  A pilot study of cidofovir in patients with kaposi sarcoma. , 2003, The Journal of infectious diseases.

[217]  J. Gutkind,et al.  Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. , 2003, Cancer cell.

[218]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[219]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[220]  D. Donnell,et al.  Phase III Vehicle-Controlled, Multi-Centered Study of Topical Alitretinoin Gel 0.1% in Cutaneous AIDS-Related Kaposi’s Sarcoma , 2001, American journal of clinical dermatology.

[221]  L. Thompson,et al.  Kaposi sarcoma of major salivary gland origin , 2000, Cancer.

[222]  D. Parkin,et al.  Cancer incidence in the African population of Harare, Zimbabwe: Second results from the cancer registry 1993–1995 , 2000, International journal of cancer.

[223]  B. Campbell,et al.  Kaposi's sarcoma of the oral cavity in a non‐aids patient: Case report and review of the literature , 1995, Head & neck.

[224]  C. Chintu,et al.  Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[225]  J. Tappero,et al.  Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection. , 1993, Journal of the American Academy of Dermatology.